Michael F. Oliver - Concepedia

Author

Michael F. Oliver

Also Known As

M F Oliver, M Oliver, M. F. OLIVER, M. Oliver, M.F. Oliver, MICHAEL F OLIVER, MICHAEL F. OLIVER, Michael F Oliver, Michael F. Oliver, Michael Oliver

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of Edinburgh Edinburgh Royal Infirmary University of California, San Francisco Brigham and Women's Hospital Harvard University

About

Michael F. Oliver is an author at University of Edinburgh specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	787
2	Public Health	9	9	501
3	Health Sciences	5	5	152
4	Applied Physiology	1	1	21
5	Biochemistry	1	1	27

Michael F. Oliver

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial Anders Olsson, Gregory G. Schwartz, Michael Szarek, European Heart Journal	2005	194
Effects of Atorvastatin on Stroke in Patients With Unstable Angina or Non-Q-Wave Myocardial Infarction David D. Waters, Gregory G. Schwartz, Anders Olsson, Circulation	2002	192
Effect of Mivazerol on Perioperative Cardiac Complications during Non-cardiac Surgery in Patients with Coronary Heart Disease Michael F. Oliver, Lee Goldman, Desmond G. Julian, Anesthesiology	1999	181
Sudden Death and Myocardial Infarction Mary Fulton, Desmond G. Julian, Michael F. Oliver Circulation Cardiogenic ShockCardiovascular DiseaseAtherosclerosisMyocardial InfarctionSudden Death	1969	109
Problems in evaluating coronary care units Michael F. Oliver, Desmond G. Julian, K. W. Donald The American Journal of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseCoronary UnitCoronary Care UnitsOutcomes Research	1967	98
Rationale and Design of the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Study11See Appendix Afor the list of participants in the MIRACL study. That Evaluates Atorvastatin in Unstable Angina Pectoris and in Non–Q-Wave Acute Myocardial Infarction Gregory G. Schwartz, Michael F. Oliver, Michael Ezekowitz, The American Journal of Cardiology Myocardial Ischemia ReductionCardiovascular EpidemiologyCardiovascular DiseasePharmacologyCardiovascular Pharmacology	1998	89
Reducing cholesterol does not reduce mortality Michael F. Oliver Journal of the American College of Cardiology Metabolic SyndromeLipid DisorderCardiovascular DiseaseHealth PolicyHyperlipidemia	1988	88
Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials. H. A. Dewar, Michael F. Oliver BMJ	1971	87
Risks of Correcting the Risks of Coronary Disease and Stroke with Drugs Michael F. Oliver New England Journal of Medicine PharmacotherapyPreventive CardiologyDrug TreatmentCardiovascular ToxicityCoronary Artery Disease	1982	81
Low Plasma Vitamins E and C Increased Risk of Angina in Scottish Men<sup>a</sup> R. A. Riemersma, David A. Wood, Cecilia C. A. MacIntyre, Annals of the New York Academy of Sciences Vascular DiseaseHyperlipidemiaPreventive CardiologyCoronary Artery DiseasePublic Health	1989	65

Page 1